Detalhe da pesquisa
1.
Long-Term Outcomes of dMMR/MSI-H Rectal Cancer Treated With Anti-PD-1-Based Immunotherapy as Curative-Intent Treatment.
J Natl Compr Canc Netw
; 22(3)2024 03 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38498975
2.
Neoadjuvant Immune Checkpoint Inhibition Improves Organ Preservation in T4bM0 Colorectal Cancer With Mismatch Repair Deficiency: A Retrospective Observational Study.
Dis Colon Rectum
; 66(10): e996-e1005, 2023 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35485833
3.
Efficacy of PD-1 inhibitors for colorectal cancer and polyps in Lynch syndrome patients.
Eur J Cancer
; 192: 113253, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37625240
4.
PD-1 blockade in neoadjuvant setting of DNA mismatch repair-deficient/microsatellite instability-high colorectal cancer.
Oncoimmunology
; 9(1): 1711650, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32042474
5.
[Chronic intermittent hypoxia decreases acute hypoxic inhibition of voltage-gated potassium channel in rat pulmonary arterial smooth muscle cells].
Sheng Li Xue Bao
; 56(5): 625-31, 2004 Oct 25.
Artigo
em Zh
| MEDLINE | ID: mdl-15497045